• The FDA published a draft guidance for industry regarding the Generic Drug User Fee Amendments of 2012 intended to offer updated answers to common questions from the generic drug industry. GDUFA establishes fees for abbreviated new drug applications, prior approval supplements to ANDAs, and drug master files, annual facility fees and a one-time fee for original ANDAs pending as of Oct. 1, 2012.